small molecule

XENICAL

ORLISTAT

Loss of exclusivity—loss of exclusivity
CompanyCHEPLAPHARM ARZNEIMITTEL GMBH

Drug detail

Brand nameXENICAL
Active ingredientORLISTAT
Strength120MG
Dosage formCAPSULE
RouteORAL
ModalitySmall molecule
FDA approvalApril 1999
Marketing statusRX

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.